Silverback Therapeutics logo
Silverback Therapeutics SBTX
$ 6.1 4.99%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Silverback Therapeutics Long Term Debt Current 2011-2024 | SBTX

Annual Long Term Debt Current Silverback Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
237 K 230 K 144 K - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
237 K 144 K 204 K